3rd Circ. Orders GSK To Trial Over Paxil Deal With Mylan
The Third Circuit on Monday revived accusations that GlaxoSmithKline LLC provided Apotex Inc. with generics of its antidepressant Paxil under a $480 million antitrust settlement despite promising that only Mylan Inc....To view the full article, register now.
Already a subscriber? Click here to view full article